These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10415634)

  • 41. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.
    van den Borne BE; Landewé RB; Goei The HS; Rietveld JH; Zwinderman AH; Bruyn GA; Breedveld FC; Dijkmans BA
    J Rheumatol; 1998 Aug; 25(8):1493-8. PubMed ID: 9712089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
    Gerards AH; Landewé RB; Prins AP; Bruyn GA; Goei Thé HS; Laan RF; Dijkmans BA
    Ann Rheum Dis; 2003 Apr; 62(4):291-6. PubMed ID: 12634224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study).
    Migliore A; Bizzi E; Massafra U; Vacca F; Martin Martin LS; Ferlito C; Podestà E; Granata M; Laganà B
    Int J Immunopathol Pharmacol; 2010; 23(3):783-90. PubMed ID: 20943048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level.
    Cobankara V; Ozatli D; Kiraz S; Oztürk MA; Ertenli I; Türk T; Apras S; Haznedaroglu IC; Calgüneri M
    Clin Rheumatol; 2004 Oct; 23(5):430-4. PubMed ID: 15278755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adverse effects of cyclosporin a observed in rheumatoid arthritis and psoriatic arthritis].
    Prajs K; Fliciński J; Przepiera-Bedzak H; Brzosko I; Ostanek L
    Ann Acad Med Stetin; 2010; 56 Suppl 1():48-51. PubMed ID: 21365941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
    Horton R; Hawks D; Lobo R
    J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.
    Pincus T; Sokka T; Chung CP; Cawkwell G
    Ann Rheum Dis; 2006 Jul; 65(7):878-83. PubMed ID: 16339290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).
    VanderBorght A; De Keyser F; Geusens P; De Backer M; Malaise M; Baeten D; Van den Bosch F; Veys EM; Raus J; Stinissen P
    J Rheumatol; 2002 Mar; 29(3):416-26. PubMed ID: 11908552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
    Ferraccioli GF; Gremese E; Tomietto P; Favret G; Damato R; Di Poi E
    Rheumatology (Oxford); 2002 Aug; 41(8):892-8. PubMed ID: 12154206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
    Aletaha D; Smolen JS
    Rheumatology (Oxford); 2002 Dec; 41(12):1367-74. PubMed ID: 12468815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis.
    Litinsky I; Paran D; Levartovsky D; Wigler I; Kaufman I; Yaron I; Yaron M; Caspi D; Elkayam O
    Cytokine; 2006 Jan; 33(2):106-10. PubMed ID: 16487722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.
    Johns KR; Littlejohn GO
    J Rheumatol; 1999 Oct; 26(10):2110-3. PubMed ID: 10529125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
    Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
    J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma 5 alpha-androstane-3 alpha,17 beta-diol and urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide, parameters of peripheral androgen action: a comparative study.
    Deslypere JP; Sayed A; Punjabi U; Verdonck L; Vermeulen A
    J Clin Endocrinol Metab; 1982 Feb; 54(2):386-91. PubMed ID: 7054226
    [No Abstract]   [Full Text] [Related]  

  • 58. [Etanercept combined with Tripterygium wilfordii polyglycoside for treatment of rheumatoid arthritis in the elderly: a clinical study].
    He WZ; Yin ZH; Gao JH; Ye ZZ; Xie Y; Kong WH; Chen YS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):267-71. PubMed ID: 24758073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness and safety of infliximab in rheumatoid arthritis: analysis from a Canadian multicenter prospective observational registry.
    Thorne C; Bensen WG; Choquette D; Chow A; Khraishi M; Atkins CJ; Kelsall JT; Lehman AJ; Shawi M; Khalil H; Nantel F; Rampakakis E; Sampalis JS; Otawa S
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1142-51. PubMed ID: 24470077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy.
    Genovese MC; Hsia E; Belkowski SM; Chien C; Masterson T; Thurmond RL; Manthey CL; Yan XD; Ge T; Franks C; Greenspan A
    J Rheumatol; 2015 Oct; 42(10):1752-60. PubMed ID: 26233509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.